Commercialization of Biotechnology and Expansion of New and Existing Business Areas
First written in FY2016. 12 of 30 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2026-H1.
2 other companies' latest entry also says "Advanced".
- FY2026-H1AdvancedAnnual report
「Sales volumes of raffinose, betaine and fructooligosaccharides increased, resulting in sales above the year-earlier level. Food business sales rose 6.1% year on year to ¥1,377 million, and operating profit increased 29.6% to ¥93 million.」
Higher sales volumes of raffinose, betaine and fructooligosaccharides resulted in higher food business sales and profit, with progress in developing related businesses including functional food ingredients. - FY2025AdvancedAnnual report
「The company will work to secure sales by developing the market for domestically produced dry yeast, the only such product in Japan, including Tokachino Yeast and Umapan Shokunin, as well as by expanding sales of liquid sweeteners containing oligosaccharides such as fructooligosaccharides.」
For the functional foods and yeast businesses, the company has presented specific growth measures: developing the market for domestically produced dry yeast and expanding sales of liquid sweeteners containing fructooligosaccharides and other ingredients. - FY2025-H1AdvancedAnnual report
「Sales volumes of fructooligosaccharides and betaine increased, resulting in sales above the year-earlier level. Food business sales rose 2.7% year on year to ¥1,298 million, and operating profit increased 162.3% to ¥71 million.」
Higher sales volumes of fructooligosaccharides and betaine resulted in higher food business sales and profit, with specific progress in developing related businesses including functional food ingredients. - FY2024AdvancedAnnual report
「The company is working to secure sales by expanding sales of liquid sweeteners containing oligosaccharides such as fructooligosaccharides.」
For the existing functional foods and oligosaccharides business, the company has presented a specific sales initiative: expanding sales of liquid sweeteners containing fructooligosaccharides and other ingredients. - FY2024-Q3AdvancedAnnual report
「Food business revenue increased 3.4% year on year to ¥1,979 million, driven by higher sales of yeast and other products, while operating profit increased 338.2% to ¥138 million through efforts to sell at appropriate prices and reduce costs.」
In addition to higher sales of yeast and other products, sales at appropriate prices and cost reductions resulted in higher sales and profit for the food business, with measurable progress reported in the development of the food business. - FY2024-Q2Food business profit increases alongside lower food ingredients salesAnnual report
「Yeast sales exceeded the year-earlier level as the company revised prices and worked to sell products at appropriate prices. Sales volumes of food ingredients such as oligosaccharides declined, resulting in sales below the year-earlier level. Food business sales rose 0.9% year on year to ¥1,264 million, and operating profit increased 82.6% to ¥27 million.」
Yeast sales increased following the price revision, while sales volumes of food ingredients such as oligosaccharides declined. The food business as a whole reported higher sales and profit, with progress in business development alongside differing performance by product. - FY2024-Q1AdvancedAnnual report
「Food business sales rose 8.0% year on year to ¥664 million due mainly to higher sales of yeast and oligosaccharides, and operating profit was ¥1 million, compared with an operating loss of ¥3 million in the year-earlier period.」
Higher sales of yeast and oligosaccharides increased food business sales, enabling a swing from an operating loss in the year-earlier period to operating profit of ¥1 million. Progress has been made in commercializing functional foods and other businesses. - FY2023-Q3AdvancedAnnual report
「Food segment revenue increased 7.8% year on year to ¥1,914 million, driven by higher sales of food ingredients such as oligosaccharides, while segment profit increased 96.0% to ¥31 million through efforts to reduce selling expenses and other costs.」
In addition to higher sales of food ingredients such as oligosaccharides, cost reductions in selling expenses and other areas resulted in higher sales and profit for the food business, securing profit of ¥31 million, up 96.0% year on year. - FY2023-Q2Food ingredients sales increase and food business returns to profitabilityAnnual report
「Sales of food ingredients such as oligosaccharides exceeded the year-earlier level as sales volumes of raffinose and fructooligosaccharides increased. Food segment sales rose 11.9% year on year to ¥1,252 million, and efforts to reduce selling expenses and other factors resulted in segment profit of ¥15 million, compared with a segment loss of ¥3 million in the year-earlier period.」
Higher sales volumes of raffinose and fructooligosaccharides increased food segment sales. Lower selling expenses also contributed, enabling the segment to swing from a loss in the year-earlier period to profitability. - FY2023-Q1Food ingredients sales increase, but higher manufacturing costs lead to a lossAnnual report
「Food segment sales rose 8.9% year on year to ¥615 million due mainly to higher sales of food ingredients such as oligosaccharides. However, earnings deteriorated due to higher manufacturing costs, resulting in a segment loss of ¥3 million, compared with segment profit of ¥6 million in the year-earlier period.」
Sales of food ingredients such as oligosaccharides increased, while higher manufacturing costs caused the food segment to swing from profit in the year-earlier period to a loss of ¥3 million. - FY2022Sluggish growth in food ingredients sales and impairment of equipmentAnnual report
「Sales volumes of oligosaccharides such as raffinose and fructooligosaccharides increased, but sales of food ingredients such as oligosaccharides remained sluggish. In addition, the profitability of production equipment at the Shimizu Bio Plant declined due to weak demand for yeast and sluggish growth in sales of fructooligosaccharides.」
While pursuing a policy of expanding food ingredients sales, the company experienced sluggish sales and lower profitability at the Shimizu Bio Plant, and recorded an impairment loss of ¥414 million. - FY2022-Q3Food ingredients sales increase, but profit declines due to higher manufacturing costsAnnual report
「Food segment sales rose 6.7% year on year to ¥1,775 million due mainly to higher sales of food ingredients such as oligosaccharides. Segment profit, however, fell 32.0% to ¥16 million due mainly to higher manufacturing costs.」
Sales of food ingredients such as oligosaccharides increased, while food segment profit fell 32.0% year on year due to higher manufacturing costs. - FY2022-Q2Food business swings to a loss while food ingredients recoverAnnual report
「Sales of household yeast declined as stay-at-home demand leveled off. Sales of food ingredients such as oligosaccharides exceeded the year-earlier level as sales volumes of raffinose and fructooligosaccharides increased. Food segment sales rose 1.6% year on year to ¥1,119 million, but higher manufacturing costs and other factors resulted in a segment loss of ¥3 million, compared with segment profit of ¥9 million in the year-earlier period.」
While stay-at-home demand for household yeast leveled off, sales volumes of products such as raffinose increased. Food segment sales rose, but the segment swung from profit in the year-earlier period to a loss due to higher manufacturing costs. - FY2022-Q1Household yeast demand levels off and food business profit declinesAnnual report
「Sales of household yeast, which had grown on stay-at-home demand stemming from the COVID-19 pandemic, leveled off, and food segment sales increased 1.4% year on year to ¥565 million. Segment profit, however, fell 48.4% to ¥6 million.」
Sales of household yeast, which had grown on stay-at-home demand, leveled off, and food segment profit fell 48.4% year on year. While the company continues to develop the food business, demand momentum has slowed. - FY2021-Q3Continued decline in functional foods sales and sustained food business profitabilityAnnual report
「Food segment sales fell 4.4% year on year to ¥1,663 million due mainly to lower sales of food ingredients such as oligosaccharides. However, cost-cutting measures and other factors resulted in segment profit of ¥23 million, compared with a loss of ¥40 million in the year-earlier period.」
Although the decline in sales of food ingredients such as oligosaccharides continued, cost-cutting measures enabled the food segment to swing from a loss in the year-earlier period to profit of ¥23 million. - FY2021-Q2Continued decline in functional foods sales and return to profitabilityAnnual report
「Although sales of liquid oligosaccharides increased, sales volumes of oligosaccharides and betaine declined, resulting in sales below the year-earlier level. Food segment sales fell 2.7% year on year to ¥1,101 million, but amid cost-cutting measures and other factors, the segment posted profit of ¥9 million, compared with a loss of ¥22 million in the year-earlier period.」
Although sales volumes of oligosaccharides and betaine continued to decline, cost-cutting measures enabled the food segment to swing from a loss in the year-earlier period to profit of ¥9 million. - FY2021-Q1Continued decline in functional foods sales and profit recoveryAnnual report
「Food segment revenue decreased 6.9% year on year to ¥557 million, as higher sales of household dry yeast were more than offset by lower sales of food ingredients such as oligosaccharides. However, cost reductions and other measures resulted in segment profit of ¥12 million, compared with segment profit of ¥0 million in the same period of the previous year.」
Although the decline in sales of food ingredients such as oligosaccharides continued, cost-cutting measures enabled the food segment to generate profit of ¥12 million, compared with zero profit in the year-earlier period. - FY2020AdvancedAnnual report
「During the fiscal year, the company launched new products, including Hokkaido Dosanko Oligo, a high-value-added liquid sweetener containing oligosaccharides, and worked to expand sales.」
While functional foods sales continued to decline, the company launched Hokkaido Dosanko Oligo as a specific measure to expand sales in the food business. - FY2020-Q3Continued decline in functional foods sales and widening food business lossesAnnual report
「Food segment sales fell 10.8% year on year to ¥1,741 million, due mainly to lower sales of food ingredients such as oligosaccharides. Although earnings from yeast improved, the impact of lower sales of oligosaccharides and other food ingredients was substantial, resulting in a segment loss of ¥40 million, compared with a loss of ¥7 million in the year-earlier period.」
The decline in sales of food ingredients such as oligosaccharides continued, and the food segment loss widened from ¥7 million in the year-earlier period to ¥40 million. Meanwhile, earnings from yeast improved. - FY2020-Q2Continued decline in functional foods sales and widening food business lossesAnnual report
「Functional foods such as oligosaccharides saw lower sales volumes for products including betaine, resulting in sales below the year-earlier level. Food segment sales fell 13.1% year on year to ¥1,132 million, and the segment posted a loss of ¥22 million, compared with a loss of ¥8 million in the year-earlier period.」
The decline in functional foods sales volume and revenue continued, and the food segment loss widened from ¥8 million in the year-earlier period to ¥22 million. - FY2020-Q1Continued decline in functional foods salesAnnual report
「Food segment sales fell 9.9% year on year to ¥598 million due to lower sales volumes of food ingredients such as oligosaccharides. Segment profit fell 94.0% to ¥0 million.」
The decline in sales volumes of food ingredients such as oligosaccharides continued, with food segment sales down 9.9% year on year and profit down 94.0% to ¥0 million. - FY2019-Q3Continued decline in functional foods salesAnnual report
「Food segment sales fell 5.2% year on year to ¥1,951 million, due mainly to lower sales of functional foods such as oligosaccharides. Including higher manufacturing costs related to capital investment, the segment posted a loss of ¥7 million, compared with segment profit of ¥135 million in the year-earlier period.」
The decline in functional foods sales continued, and the food segment swung from profit in the year-earlier period to a loss. - FY2019-Q2Continued decline in functional foods sales volume and revenueAnnual report
「Functional foods such as oligosaccharides saw lower sales volumes for products including oligosaccharides, resulting in sales below the year-earlier level.」
Sales volume and revenue for oligosaccharides and other functional foods continue to decline. No withdrawal of the commercialization policy is disclosed. - FY2019-Q1Decline in functional foods sales volume and revenueAnnual report
「Food segment sales fell 6.4% year on year to ¥664 million, due mainly to lower sales volumes of functional foods such as oligosaccharides. Segment profit fell 90.9% to ¥5 million, due mainly to higher manufacturing costs for products such as yeast.」
Lower sales volumes of functional foods reduced food segment sales, and food segment profit also declined substantially. - FY2018-Q2Decline in functional food salesAnnual report
「Functional foods such as oligosaccharides saw lower sales volumes for products including raffinose, resulting in sales below the year-earlier level.」
The disclosure states that sales volume and sales of oligosaccharides in the functional foods business were below the year-earlier levels, but does not mention any change in the policy for commercializing the business. - FY2017AdvancedAnnual report
「Sales volume of oligosaccharides among functional foods increased, and revenue exceeded the previous fiscal year. Food segment revenue was ¥2,668 million, up 0.7% from the previous fiscal year, while segment profit was ¥281 million, down 11.3% from the previous fiscal year.」
It reports higher sales volume of oligosaccharides among functional foods and higher food segment revenue year on year, showing progress in developing peripheral businesses. Segment profit, however, declined. - FY2017-Q3AdvancedAnnual report
「Food segment revenue increased 1.2% year on year to ¥2,014 million, driven by higher sales volume of functional foods such as oligosaccharides, while segment profit increased 7.9% to ¥243 million.」
It reports that food segment revenue and profit increased year on year against a backdrop of higher sales volume of functional foods such as oligosaccharides. - FY2017-Q2AdvancedAnnual report
「Sales of functional foods such as oligosaccharides and betaine were strong, and revenue exceeded the same period of the previous year. Food segment revenue was broadly in line with the same period of the previous year at ¥1,313 million, while segment profit increased 13.6% year on year to ¥149 million.」
It reports strong sales of functional foods such as oligosaccharides and betaine, and a 13.6% year-on-year increase in food segment profit. - FY2017-Q1AdvancedAnnual report
「Food segment revenue increased 6.8% year on year to ¥707 million, mainly owing to higher sales volume of functional foods such as oligosaccharides, while segment profit increased 36.9% to ¥96 million.」
It reports higher sales volume of functional foods such as oligosaccharides, together with increases in food segment revenue and profit, indicating progress in commercializing new and peripheral businesses. - FY2016First statedAnnual report
「We will put the biotechnology developed through many years of research into practical applications, develop new businesses and expand the scope of existing businesses.」
It sets out a policy of applying its accumulated research to biotechnology and expanding its business fields.